Comparison of Patients With Cancer Events Using AMPLIFY vs Control
Adapted from Carragee EJ et al. Cancer Risk After Use of Recombinant Bone Morphogenetic Protein-2 for Spinal Arthrodesis. J Bone Joint Surg Am. 2013;95:1537–1545. With permission from The Journal of Bone and Joint Surgery, Inc.